Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation

Bone Marrow Transplantation
S Oziel-TaiebD Blaise

Abstract

A 38-year-old man, blood group A+, was allotransplanted for multiple myeloma from his fully matched sister, blood group O+. Anti-A antibodies IgG and IgM titres of the donor were low. Allogeneic peripheral blood stem cells were harvested by leukapheresis after subcutaneous administration of G-CSF. Rapid engraftment occurred since 5.6 x 10(9)/l leukocytes were achieved on day +9 post-transplant. At this time a severe immune haemolytic syndrome occurred and direct antiglobulin test was positive (IgG and C3d). Elution showed an anti-A specificity. Evolution was rapidly unfavourable related to multiorgan failure. The patient died on day +20 post-transplant.

Citations

Sep 8, 2011·Bone Marrow Transplantation·S D RowleyP Bhattacharyya
Mar 16, 2002·Transfusion·Robert J SokolHelen F Barker
Apr 19, 2002·Transfusion·Mara HareuveniNeomi Rahimi-Leveen
Apr 28, 2007·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·J-V MalfusonS Maury
May 26, 2004·Transfusion·Annette Sauer-HeilbornJeffrey McCullough
Feb 26, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J ShorttM F Cole-Sinclair
Nov 21, 2008·Journal of Clinical Laboratory Analysis·Hee-Jung ChungSeog-Woon Kwon
Mar 9, 2011·Transfusion·Jennifer Daniel-Johnson, Joseph Schwartz
Nov 24, 2004·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·N ContentinH Tilly
Aug 29, 2006·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Georg StussiJörg D Seebach
Mar 28, 2006·Transfusion Medicine Reviews·Lawrence D Petz
Jul 26, 2005·Seminars in Hematology·Lawrence D Petz
Jun 29, 2005·Transplant Immunology·Primoz RozmanMateja Bohinjec
Feb 18, 2003·British Journal of Haematology·Je-Hwan LeeKyoo-Hyung Lee
Jun 28, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nandita KheraMichael Linenberger
May 24, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Elizabeth M StaleyHuy P Pham
Jul 6, 2004·Bone Marrow Transplantation·R RaimondiUNKNOWN Gruppo Italiano Trapianto di Midolla Osseo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.